Drug repurposing from an academic perspective
- 29 February 2012
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Therapeutic Strategies
- Vol. 8 (3-4), 61-69
- https://doi.org/10.1016/j.ddstr.2011.10.002
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The CTSA Pharmaceutical Assets Portal – a public–private partnership model for drug repositioningDrug Discovery Today: Therapeutic Strategies, 2012
- Simultaneous in vitro molecular screening of protein-peptide interactions by flow cytometry, using six Bcl-2 family proteins as examplesNature Protocols, 2011
- Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer‐Aided Drug RepurposingMolecular Informatics, 2011
- Discovery of Very Late Antigen-4 (VLA-4, α4β1 Integrin) Allosteric AntagonistsOnline Journal of Public Health Informatics, 2011
- PREDICT: a method for inferring novel drug indications with application to personalized medicineMolecular Systems Biology, 2011
- Real-time Analysis of Conformation-sensitive Antibody Binding Provides New Insights into Integrin Conformational RegulationOnline Journal of Public Health Informatics, 2009
- Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirusProceedings of the National Academy of Sciences of the United States of America, 2008
- The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patientsDrug Discovery Today, 2008
- A surface on the androgen receptor that allosterically regulates coactivator bindingProceedings of the National Academy of Sciences of the United States of America, 2007
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004